{
    "Trade/Device Name(s)": [
        "Aptima Trichomonas vaginalis Assay"
    ],
    "Submitter Information": "Hologic, Inc.",
    "510(k) Number": "K231316",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122062"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OUY"
    ],
    "Summary Letter Date": "May 5, 2023",
    "Summary Letter Received Date": "May 8, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3860"
    ],
    "Regulation Name(s)": [
        "Trichomonas Vaginalis Nucleic Acid Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Trichomonas vaginalis rRNA"
    ],
    "Specimen Type(s)": [
        "Clinician-collected endocervical swab",
        "Clinician-collected vaginal swab",
        "Patient-collected vaginal swab",
        "Female urine",
        "Male urine",
        "Specimens collected in PreservCyt Solution"
    ],
    "Specimen Container(s)": [
        "Specimen transport tube",
        "PreservCyt Solution container",
        "Urine transport medium tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Panther system",
        "Tigris instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Target capture",
        "Transcription-mediated amplification (TMA)",
        "Hybridization protection assay (HPA)"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Aptima Trichomonas vaginalis nucleic acid amplification assay for detection of T. vaginalis rRNA on Panther system",
    "Indications for Use Summary": "Qualitative detection of Trichomonas vaginalis rRNA from vaginal swabs, endocervical swabs, and urine specimens (male and female) using the Panther system to aid diagnosis of trichomoniasis",
    "fda_folder": "Immunology"
}